Logo
Your free order overview
You currently have not items to display
Logo
Your contact details

This is a required field

Logo
Thank you!

Thank you for choosing Janssen Medical Cloud for ordering your materials.

Lifelong Learning in Hematology

There has been significant progress in the treatment of people diagnosed with blood cancers over the past 50 years. Our leadership has advanced transformative therapies for hematologic malignancies, and we are committed to continuing to lead in the evolution of our understanding and treatment of these diseases. Our learning platform brings together the latest resources, expert insights, treatment guidelines, and partnerships to deliver unbiased and credible educational offerings.

Lifelong Learning in Hematology
Multiple Myeloma

Multiple Myeloma

Survival outcomes in multiple myeloma have significantly improved thanks to decades of treatment advances. With more than half of the 11 innovative therapies approved for its treatment in the past two decades, Johnson & Johnson has helped transform patients’ lives with numerous approved innovative treatments. We aim to develop curative therapies, with urgency, and shifting the treatment paradigm from “treat-to-progression” to “treat-to-cure”.

Amyloidosis

Amyloidosis

Amyloidosis is a rare and serious disease in which amyloid protein build up on organs and tissues can lead to life-threatening organ failure. We are focused on understanding whether standard of care plus a new, subcutaneous version of an existing therapy for other hematologic malignancies will benefit patients.

B-cell malignancies

B-cell malignancies

More than a decade ago, we co-developed and delivered a globally approved, first-in-class treatment for certain B-cell malignancies, including chronic lymphocytic leukemia, previously treated mantle cell lymphoma, Waldenström’s macroglobulinemia, and previously treated marginal zone lymphoma.

Myeloid malignancies

Myeloid malignancies

We are committed to bringing forth new treatment options for patients with acute myeloid leukemia (AML) and myclodysplastic syndrome (MDS) and have advanced a comprehensive development program with novel bispecific approaches as well as other novel targets with transformational potential.

Our Partnerships

We are committed to partnering with medical societies and other organisations to enhance healthcare outcomes and foster professional education.

Recently Added

Recently Added

Recently Added

Here you can find the latest educational content on our website, featuring up-to-date resources, articles, and insights to support your learning journey.

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit sed do

Button Text →

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit sed do

Button Text →

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit sed do

Button Text →

Hematology Learning Centre

Browse educational formats tailored to enhance daily practice. Our learning centre is focused on meeting the evolving needs of healthcare professionals while developing the diverse skills necessary for delivering high quality care.

Scientific Education

Dive into our extensive collection of scientific educational content designed for healthcare professionals. Offering evidence based resources that explore the latest advancements in medicine and healthcare.

Learning Tools

Explore our educational tools, designed to enhance your knowledge and skills.

Events Centre

Stay informed with our Event Centre – your hub for medical education events, expert faculty interviews, and clinical insights. Browse on-demand content from past events and hear from leaders shaping patient care.

Expert Insights: Answers from Leading Specialists

Gain valuable insights from leading experts in the field as they share their knowledge on key topics and provide informed answers to common questions. Stay informed and enhance your understanding with expert perspectives!

View expert response

Register or Log in to Access More →

Note: To ask a question or access full FAQ archives, register or log in to J&J Medical Cloud.

Scientific Committee & Faculty

Discover the experts shaping our educational programs. Dive into the bios of this global network of leading specialists and discover their unique perspectives.

Meet the Faculty →

Lorem ipsum dolor sit amet lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consect acing elit, sed do eiusmod tempor ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud.

Lorem ipsum dolor sit amet lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consect acing elit, sed do eiusmod tempor ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud.

Lorem ipsum dolor sit amet lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consect acing elit, sed do eiusmod tempor ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud.

Our Commitment

Therapeutic Areas

Our scientists and researchers are pioneering the path from lab to life and championing patients each step of the way.

Expert-Driven Education

Our educational programs are developed and reviewed in partnership with a global network of healthcare leaders.

Support‑ Focused

We work with medical societies to support joint initiatives that enhance healthcare outcomes and foster professional education.

Connecting Scientific Expertise

Supporting healthcare professionals to engage in ongoing discussions about the latest scientific advancements.

Our Pledge to Medical Education

Contact us

To report an Adverse Event (medication side effect) or a Product Quality Complaint (an issue with one of our products), please select the appropriate link from the Contact dropdown menu. To submit a medical information request, choose the Medical Information page.

CP-534303 - July 2025